These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 1612072

  • 1. Management of hyperlipidemia in diabetes mellitus.
    Dunn FL.
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):395-414. PubMed ID: 1612072
    [Abstract] [Full Text] [Related]

  • 2. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Jun; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 3. Hyperlipidemia: forestalling complications in older diabetics.
    Chait A.
    Geriatrics; 1985 Apr; 40(4):71-3, 76-8. PubMed ID: 3884443
    [Abstract] [Full Text] [Related]

  • 4. [Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment].
    Keller U, Golay A, Pometta D.
    Schweiz Rundsch Med Prax; 1990 Oct 09; 79(41):1199-204. PubMed ID: 2237046
    [Abstract] [Full Text] [Related]

  • 5. Hyperlipidemia in children with type 2 diabetes mellitus.
    Taha D.
    J Pediatr Endocrinol Metab; 2002 Apr 09; 15 Suppl 1():505-7. PubMed ID: 12017224
    [Abstract] [Full Text] [Related]

  • 6. Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data.
    Lewis GF.
    Can J Cardiol; 1995 May 09; 11 Suppl C():24C-28C. PubMed ID: 7750045
    [Abstract] [Full Text] [Related]

  • 7. [Disorders of lipid metabolism in diabetes mellitus].
    Biesenbach G.
    Wien Med Wochenschr Suppl; 1989 May 09; 105():9-17. PubMed ID: 2694631
    [Abstract] [Full Text] [Related]

  • 8. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA.
    Acta Endocrinol Suppl (Copenh); 1985 May 09; 272():27-30. PubMed ID: 3869424
    [Abstract] [Full Text] [Related]

  • 9. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul 09; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 09; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 11. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
    Seyoum B, Abdulkadir J, Berhanu P, Feleke Y, Mengistu Z, Worku Y, Ayana G.
    Ethiop Med J; 2003 Jan 09; 41(1):1-8. PubMed ID: 12764995
    [Abstract] [Full Text] [Related]

  • 12. [Hyperlipidemia in diabetes mellitus. Pathogenesis, diagnosis and drug therapy--a review].
    Johansen K.
    Ugeskr Laeger; 1990 Feb 26; 152(9):584-8. PubMed ID: 2408221
    [Abstract] [Full Text] [Related]

  • 13. Prevention of atherosclerosis in diabetes: emphasis on treatment for the abnormal lipoprotein metabolism of diabetes.
    Kim DK, Escalante DA, Garber AJ.
    Clin Ther; 1993 Feb 26; 15(5):766-78; discussion 765. PubMed ID: 8269443
    [Abstract] [Full Text] [Related]

  • 14. Diabetic dyslipidemia.
    Chahil TJ, Ginsberg HN.
    Endocrinol Metab Clin North Am; 2006 Sep 26; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [Abstract] [Full Text] [Related]

  • 15. [Diabetes mellitus and lipoproteins].
    Somogyi A.
    Orv Hetil; 1993 Oct 24; 134(43):2371-7. PubMed ID: 8233456
    [Abstract] [Full Text] [Related]

  • 16. [Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics].
    Mudríková T, Tkác I, Takác M.
    Vnitr Lek; 1994 Apr 24; 40(4):250-4. PubMed ID: 8184588
    [Abstract] [Full Text] [Related]

  • 17. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S, Terzi AB, Tousoulis D, Koulouris S.
    Int J Cardiol; 2008 May 07; 126(1):3-12. PubMed ID: 17689745
    [Abstract] [Full Text] [Related]

  • 18. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
    McKenney JM.
    Pharmacotherapy; 1993 May 07; 13(4):340-52. PubMed ID: 8361860
    [Abstract] [Full Text] [Related]

  • 19. Dyslipoproteinemia and diabetes.
    Orchard TJ.
    Endocrinol Metab Clin North Am; 1990 Jun 07; 19(2):361-80. PubMed ID: 2192878
    [Abstract] [Full Text] [Related]

  • 20. Pathophysiology of hyperlipidemia in diabetes mellitus.
    Abbate SL, Brunzell JD.
    J Cardiovasc Pharmacol; 1990 Jun 07; 16 Suppl 9():S1-7. PubMed ID: 1710739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.